| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.905 | 0 | 0 | 1994 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2016 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.923 | 0 | 0 | 1993 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2011 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.400 | None | 0.950 | 0 | 0 | 1993 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.350 | None | 1.000 | 0 | 0 | 1995 | 2016 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 1999 | 1999 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 1995 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.600 | None | 0 | 0 | |||||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 1993 | 2017 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.500 | None | 0 | 0 | |||||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.420 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2016 | 2016 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2002 | 2002 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2010 | 2020 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 |